SARS-CoV-2 non-structural proteins (nsps)

SARS-CoV-2 non-structural proteins (nsps) are a group of 16 proteins (nsp1 to nsp16) encoded by the ORF1a and ORF1ab genes of the viral genome (UniProt P0DTD1). These proteins are essential for the viral life cycle, primarily functioning in the assembly of the replicase-transcriptase complex (RTC) and the processing of viral polyproteins (PubMed: 32464098). Key enzymes within this group include the main protease (Mpro/nsp5), the papain-like protease (PLpro/nsp3), and the RNA-dependent RNA polymerase (RdRp/nsp12) (NIH: PMC7112328). Because these proteins are critical for viral replication and are highly conserved across coronavirus variants, they serve as primary targets for antiviral drug development (PubMed: 33082294). Drugs like nirmatrelvir target the protease activity to prevent polyprotein cleavage, while remdesivir and molnupiravir target the polymerase to disrupt RNA synthesis (PubChem). Inhibiting these proteins effectively halts the production of new viral particles, making them central to the therapeutic management of COVID-19.

Other names

Non-structural proteinsnspsReplicase polyprotein 1aReplicase polyprotein 1abSARS-CoV-2 replicase complex

Inhibition of viral proteases (nsp5, nsp3) to prevent polyprotein processing or inhibition of RNA-dependent RNA polymerase (nsp12) to terminate viral RNA synthesis.